Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior. | ...

UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

At issue is the role pharmacy benefit mangers play in taking large discounts on drugs that advocates say are not passed along ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Operator Good morning and welcome to the UnitedHealth Group fourth quarter and full year 2024 earnings conference call. A ...

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...

An informal coalition of patient advocacy organizations, independent pharmacists and local business groups in Connecticut ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...